|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Fraser Laboratories for Diabetes Research, McGill University, Montreal, QC, Canada
2 Department of Advanced Biological Sciences For Regeneration, Tohoku University, Sendai, Miyagi, Japan
3 Department of Biochemistry, Tohoku University, Sendai, Miyagi, Japan
4 Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland
* To whom correspondence should be addressed. E-mail: jun-li.liu{at}mcgill.ca.
We have recently reported that Pdx1-Cre-mediated, whole pancreas inactivation of IGF-I gene (in PID mice) results in increased
-cell mass and significant protection against both type 1 and type 2 diabetes. As the phenotype is unlikely a direct consequence of IGF-I deficiency, current study was designed to explore possible activation of pro-islet factors in PID mice, using a whole genome DNA microarray. As a result, multiple members of the Reg family genes (Reg2, 3
and 3
; previously not known to promote islet cell growth) were significantly upregulated in the pancreas. This finding was subsequently confirmed by Northern blot and/or real-time PCR, which exhibited 2 to 8 fold increases in the level of these mRNAs. Interestingly, these Reg family genes were also activated following streptozotocin-induced
-cell damage and diabetes (wild-type T1D mice) when islet cells are undergoing regeneration. Immunohistochemistry revealed increased Reg proteins in exocrine as well as endocrine pancreas, and suggested their potential role in
-cell neogenesis in PID or T1D mice. Previously, other Reg proteins (Reg1 and INGAP) have been shown to promote islet cell replication and neogenesis. These uncharacterized Reg proteins may play a similar but more potent role, not only in normal islet cell growth in PID mice, but also in islet cell regeneration after T1D.
This article has been cited by other articles:
![]() |
K. Robertson, Y. Lu, K. De Jesus, B. Li, Q. Su, P. K. Lund, and J.-L. Liu A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E928 - E938. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |